Recently Released Market Study: Mexico Pharmaceuticals & Healthcare Report Q4 2012
BMI View: Mexico has swapped positions with Brazil within BMI's Risk/Reward Rating assessment in Q412, indicating the possibility of fundamental changes in the two markets due to the macroeconomic factors. We note that the improving regulatory environment as well as the outperforming economic growth makes Mexican pharmaceutical market more attractive to multinational drugmakers.
View full press release